Recent News

• 11.03.2025 - Kamada to Announce Third Quarter and Nine Months Ended September 30, 2025 Financial Results on November 10, 2025
• 10.29.2025 - Kamada to Present at the Stifel 2025 Healthcare Conference
• 09.02.2025 - Kamada to Participate in Upcoming September Investor Conferences
• 08.13.2025 - Kamada Reports Strong Second Quarter and First Half 2025 Financial Results with 11% Year-Over-Year 6-Month Top Line Growth and a 35% Increase in Profitability; Raises Full-Year Profitability Guidance
• 08.11.2025 - Kamada Announces FDA Approval of its Plasma Collection Center in Houston, Texas
• 08.06.2025 - Kamada to Announce Second Quarter and First Half Ended June 30, 2025 Financial Results on August 13, 2025
• 06.17.2025 - Kamada Confirms Continuous Global Business Operations and Products Availability Despite Recent Events in the Middle East

Recent Filings

• 10.23.2025 - EX-99.1 EX-99.1
• 10.23.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 09.02.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 09.02.2025 - EX-99.1 EX-99.1
• 08.13.2025 - EX-99.1 EX-99.1
• 08.13.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 08.11.2025 - EX-99.1 EX-99.1
• 08.11.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 08.06.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 08.06.2025 - EX-99.1 EX-99.1